Skip to main content
Fig. 9 | BMC Medicine

Fig. 9

From: Osimertinib in combination with anti-angiogenesis therapy presents a promising option for osimertinib-resistant non-small cell lung cancer

Fig. 9

T cells subtype analysis between R-O and S-O groups and between R-O+A and R-O groups. A T Cell subtype cluster visualization by UMAP dimension reduction analysis. B Function clusters of specific markers for subtype annotation. C The relative abundance of various subtype T cell components was compared. D Differences in function enrichment were noted in those cell subtypes

Back to article page